Alibaba Health (0241.HK)

HKSEHealthcare

HK$ 6.83
+HK$ 0.03 (+0.4%)
Last close

January 21, 2026 at 08:00 UTC

Interactive Chart
0241.HK
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Alibaba Health

Name

Alibaba Health

CEO

Difan Shen

Industry

Healthcare

Year Founded

1998

Employees

1,422

Alibaba Health Information Technology Limited is a digital health company that connects pharmacy e-commerce with online medical services and data tools. Through a platform anchored in consumer health, the company links product discovery with verified fulfillment and after-sales care. Its operating model blends self-operated retail with marketplace services under a unified brand architecture. Clinical support channels host consultation, prescription routing, and follow-up care so users can complete a journey within a single account. Enterprise solutions address drug traceability and compliance workflows that fit policy requirements. Within the healthcare and communication services sector, the company frames its ecosystem as a bridge across patients and providers while maintaining privacy and safety controls.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 14 Buy, 8 Hold, 2 Sell
Buy14
Hold8
Sell2
Fundamentals & Financials
Revenue (TTM)
HK$ 40B
Net Income (TTM)
HK$ 2.3B
EPS (TTM)
HK$ 0.065
ROA (TTM)
9.07%
Current Ratio
2.71
Dividend Yield
-

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
RevenueHK$ 16,589M
Cost of SalesHK$ 12,440M
Gross ProfitHK$ 4,149M
Operating IncomeHK$ 1,112M
Net IncomeHK$ 1,258M
EPSHK$ 0
Technical Indicators

Alibaba Health's Technical Indicators Summary

The technical outlook for 0241.HK presents a mixed picture, contributing to a neutral overall stance. The ADX indicates a strong underlying trend, supported by robust volume activity as reflected in the rising OBV. Momentum indicators like the MACD and RSI suggest moderate strength, while price remains above key moving averages across short to long terms, signaling some bullish bias. However, the recent price sits just below the VWAP and classic pivot level, which may act as resistance. Meanwhile, volatility remains relatively elevated, as shown by the ATR, pointing to some uncertainty. Together, these factors balance each other, resulting in a neutral technical assessment for now.

Buy
14 signals
Neutral
8 signals
Sell
2 signals
Overall: Neutral33% Neutral signals
IndicatorValue
RSI (14)
60.04
Stochastic %K (14, 3, 3)
56.18
CCI (20)
80.02
WPR (14)
-45.45
Momentum (10)
1.08
MFI
66.16
MACD Level (12, 26)
0.38
Bollinger Bands
$4.22 - $7.47
ATR (14)
$0.36 (5.38%)
ADX (14)
42.80
OBV
4,072,051,080
VWAP
$6.64
Classic Pivot Point
$6.62
Fibonacci Pivot Point
$6.62
Simple Moving Averages
$5.37 - $6.47(5 indicators)
Exponential Moving Averages
$5.37 - $6.47(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

0241.HK closed the last trading session with a small but positive move, up 2.83% versus the prior day. Houston Texans' defense dominates, causing turnovers and sacking Rodgers multiple times in playoff blowout.

Price Change

from HK$ 6.36 close

+HK$ 0.18

Trading Volume

Above avg 93.5M

312.2M

vs S&P 500 Today

Inline with Market

+0.02%

52-Week Position

Upper range

77.6%

Updated: January 13, 2026 at 13:14 UTC

Quote Summary
OpenPrevious Close
HK$ 6.54HK$ 6.61
Day Range52 Week Range
HK$ 6.54 - HK$ 6.92HK$ 3.31 - HK$ 7.91
VolumeAvg. Volume
173.7M111.1M
Market CapP/E Ratio
HK$ 109.8B52.4